Sally Clive
Impact in
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
Papers in
- Oncology 23
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 4
- Cancer Diagnosis and Treatment 4
- PARP inhibition in cancer therapy 3
-
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- J. Gardiner (1 shared paper)Renaud Léonard (1 shared paper)Christopher J. Weir (2 shared papers)J. Michael Dixon (1 shared paper)Thomas Jaki (2 shared papers)Mark Kagan (2 shared papers)Margaret M. Woo (2 shared papers)Michelle D. Sakala (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Chemotherapy and Pharmacology (5 papers)British Journal of Cancer (4 papers)Annals of Oncology (2 papers)Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Sally Clive
28 papers receiving 483 citations
Peers
Comparison fields: 5 of 89
- Statistics and Probability 76
- Oncology 190
- Hematology 58
- Cancer Research 62
- Dermatology 34
Countries citing papers authored by Sally Clive
This map shows the geographic impact of Sally Clive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Clive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Clive more than expected).
Fields of papers citing papers by Sally Clive
This network shows the impact of papers produced by Sally Clive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Clive. The network helps show where Sally Clive may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally Clive, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 61 | |
| 2 | 2012 | 51 | |
| 3 | 2013 | 45 | |
| 4 | 2017 | 44 | |
| 5 | 2010 | 42 | |
| 6 | 2013 | 39 | |
| 7 | 2014 | 36 | |
| 8 | 2002 | 30 | |
| 9 | 2010 | 24 | |
| 10 | 2011 | 17 | |
| 11 | Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist. | 2001 | 17 |
| 12 | 2014 | 13 | |
| 13 | 2001 | 13 | |
| 14 | 2018 | 10 | |
| 15 | 2009 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2013 | 7 | |
| 19 | 2020 | 5 | |
| 20 | 2019 | 4 |
About Sally Clive
Sally Clive is a scholar working on Oncology, Molecular Biology, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 30 papers that have together received 500 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Diagnosis and Treatment (4 papers), PARP inhibition in cancer therapy (3 papers), Statistical Methods in Clinical Trials (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Optimal Experimental Design Methods (3 papers). The work is most often cited by research in Statistics and Probability (76 citations), Oncology (190 citations), Hematology (58 citations), Cancer Research (62 citations) and Dermatology (34 citations). Sally Clive has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include J. Gardiner, Renaud Léonard, Christopher J. Weir, J. Michael Dixon, Thomas Jaki, Mark Kagan, Margaret M. Woo, Michelle D. Sakala, Margaret Squier and Christopher R. Garrett. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.